UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC

Journal of hepatology, 2017, Vol.66 (1), p.S445-S446

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers

Annals of oncology, 2011-04, Vol.22 (4), p.986-987

2011

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases

The Journal of immunology (1950), 2001-06, Vol.166 (12), p.7634-7640

2001

Link zum Volltext

Verfügbarkeit prüfen

The Alternatively Spliced Domain TnFnIII A1A2 of the Extracellular Matrix Protein Tenascin-C Suppresses Activation-Induced T Lymphocyte Proliferation and Cytokine Production

The Journal of immunology (1950), 2001-12, Vol.167 (11), p.6431-6440

2001

Link zum Volltext

Verfügbarkeit prüfen

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3

The Journal of experimental medicine, 1999-03, Vol.189 (6), p.895-906

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.7253-7261

2000

Link zum Volltext

Verfügbarkeit prüfen

A peripheral circulating compartment of natural naive CD4 Tregs

The Journal of clinical investigation, 2005-07, Vol.115 (7), p.1953-1962

2005

Link zum Volltext

Verfügbarkeit prüfen

Ectopic Human Telomerase Catalytic Subunit Expression Maintains Telomere Length But Is Not Sufficient for CD8+ T Lymphocyte Immortalization

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.4978-4984

2000

Link zum Volltext

Verfügbarkeit prüfen

A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy

The Journal of immunology (1950), 2001-11, Vol.167 (10), p.5852-5861

2001

Link zum Volltext

Verfügbarkeit prüfen

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

The Journal of experimental medicine, 1999-06, Vol.189 (11), p.1747-1756

1999

Link zum Volltext

Verfügbarkeit prüfen

Application of support vector machines for T-cell epitopes prediction

Bioinformatics, 2003-10, Vol.19 (15), p.1978-1984

2003

Link zum Volltext

Verfügbarkeit prüfen

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

The Journal of experimental medicine, 1999-09, Vol.190 (5), p.705-716

1999

Link zum Volltext

Verfügbarkeit prüfen

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

Haematologica (Roma), 2013-02, Vol.98 (2), p.316-322

2013

Link zum Volltext

Verfügbarkeit prüfen

Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells

Journal of immunotherapy (1997), 2009-02, Vol.32 (2), p.101

2009

Link zum Volltext

Verfügbarkeit prüfen

FRI-072 - Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC

Journal of hepatology, 2017, Vol.66 (1), p.S445-S446

2017

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

The Journal of experimental medicine, 1998-11, Vol.188 (9), p.1641-1650

1998

Link zum Volltext

Verfügbarkeit prüfen

Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression

The Journal of immunology (1950), 2000-02, Vol.164 (3), p.1148-1152

2000

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1750-1758

1998

Link zum Volltext

Verfügbarkeit prüfen

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4499-4506

2000

Link zum Volltext

Verfügbarkeit prüfen

Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma

The Journal of immunology (1950), 2002-02, Vol.168 (4), p.1717-1722

2002

Link zum Volltext

Verfügbarkeit prüfen

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma

Immunological reviews, 2002-10, Vol.188 (1), p.81-96

2002

Link zum Volltext

Verfügbarkeit prüfen

Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum

The Journal of immunology (1950), 1995-04, Vol.154 (8), p.3922

1995

Link zum Volltext

Verfügbarkeit prüfen

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

Proceedings of the National Academy of Sciences - PNAS, 2002-08, Vol.99 (16), p.10629-10634

2002

Link zum Volltext

Verfügbarkeit prüfen

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

The Journal of experimental medicine, 1999-09, Vol.190 (6), p.775-782

1999

Link zum Volltext

Verfügbarkeit prüfen

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

The Journal of experimental medicine, 2002-02, Vol.195 (4), p.485-494

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(125)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Humans
(86)
Life Sciences & Biomedicine
(85)
Immunology
(62)
T-Lymphocytes, Cytotoxic - Immunology
(45)
Melanoma - Immunology
(41)
Antigens, Neoplasm - Immunology
(36)
Neoplasm Proteins - Immunology
(36)
Amino Acid Sequence
(35)
Biological And Medical Sciences
(33)
Peptide Fragments - Immunology
(30)
Mart-1 Antigen
(28)
Molecular Sequence Data
(28)
Medical Sciences
(25)
Animals
(24)
Cd8-Positive T-Lymphocytes - Immunology
(23)
Oncology
(23)
Epitopes, T-Lymphocyte - Immunology
(22)
Tumor Cells, Cultured
(21)
Hla-A2 Antigen - Immunology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC

Expression of MAGE-A antigens is frequent in triple-negative breast cancers but does not correlate with that of basal-like markers

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases

The Alternatively Spliced Domain TnFnIII A1A2 of the Extracellular Matrix Protein Tenascin-C Suppresses Activation-Induced T Lymphocyte Proliferation and Cytokine Production

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

A peripheral circulating compartment of natural naive CD4 Tregs

Ectopic Human Telomerase Catalytic Subunit Expression Maintains Telomere Length But Is Not Sufficient for CD8+ T Lymphocyte Immortalization

A New Generation of Melan-A/MART-1 Peptides That Fulfill Both Increased Immunogenicity and High Resistance to Biodegradation: Implication for Molecular Anti-Melanoma Immunotherapy

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

Application of support vector machines for T-cell epitopes prediction

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer

Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells

FRI-072 - Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression

Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients

Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma

Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum

Differential Presentation of a Soluble Exogenous Tumor Antigen, NY-ESO-1, by Distinct Human Dendritic Cell Populations

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

Thymic selection generates a large T cell pool recognizing a self-peptide in humans

Suchergebnisse filtern